Committee Chair
Scientific aims
- Identification of gene variants associated to predisposition to leukemia/lymphoma, comorbidities and heterogeneous drug response
- Understanding pathogenic mechanisms
- Translation into to clinical protocols (including guidelines)
Activities and Projects
-
COST-Legend (2018-2022): The European Union-funded COST Action (LEukaemia GENe Discovery by data sharing, mining, and collaboration – LEGEND)
An international and multidisciplinary collaboration between clinicians and researchers that covered a range of aspects of genetic predisposition in childhood leukemia
-
'Origin': I-BFM ALL Host Genetic Variation Working Group
Coordinated by Christian Peter Kratz, Martin Stanulla, Hélène Cavé
-
Coordination with the SIOPE-Host Genome group
-
Introduction of easy tools to recognize leukemia predisposition in different clinical protocol: by several members
-
Two editions (2019, 2021) of the ‘Predisposition to hereditary Leukemia and Lymphoma Training School” (COST-Action)
Collaborative projects:
-
Cohesin genes variants in ALL
G. Cazzaniga (IT), J. Hauer (DE)
-
ELEGANT Study (Exploring Leukemia: Education, Genetics, And Novel Technologies)
K. Schmiegelow (DK)
-
Family-based analysis of germline variants of children with leukemia/lymphoma
-
Lymphoid malignancies in children with AT
Sarah Elitzur (IL)
-
Mono- and digenic germline predisposition in BCP-ALL
F.Auer, J.Hauer, A.Borkhardt (DE) and others
-
Mutational patterns in tumors of children with NBS and AT
Dilys Weijers (NL)
Selected publications
Committee Members
- Franziska Auer
- Andishe Attarbaschi
- Laura Bettini
- Arndt Borkhardt
- Helene Cavé
- Sarah Elitzur
- Adela Escudero
- Grazia Fazio
- Ute Fischer
- Julia Hauer
- Shai Izraeli
- Marjolijn Jongmans
- Roland Kuiper
- Tim Lammens
- Jelena Lazic
- Jan Loeffen
- Luca Lo Nigro
- Ugur Ozbek
- Agata Pastorczak
- Tim Ripperger
- Kjeld Schmiegelow
- Martin Stanulla
- Masatoshi Takagi
- Jan Trka
- Esmé Waanders
- Jan Zuna
- and many other regular and irregular participants